[HTML][HTML] Blood-based cancer biomarkers in liquid biopsy: a promising non-invasive alternative to tissue biopsy
J Marrugo-Ramírez, M Mir, J Samitier - International journal of molecular …, 2018 - mdpi.com
Cancer is one of the greatest threats facing our society, being the second leading cause of
death globally. Currents strategies for cancer diagnosis consist of the extraction of a solid …
death globally. Currents strategies for cancer diagnosis consist of the extraction of a solid …
Molecular mechanisms of the preventable causes of cancer in the United States
Abstract Annually, there are 1.6 million new cases of cancer and nearly 600,000 cancer
deaths in the United States alone. The public health burden associated with these numbers …
deaths in the United States alone. The public health burden associated with these numbers …
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Earlier detection is key to reducing cancer deaths. Here, we describe a blood test that can
detect eight common cancer types through assessment of the levels of circulating proteins …
detect eight common cancer types through assessment of the levels of circulating proteins …
Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance
Background & Aims Screening of individuals who have a high risk of pancreatic ductal
adenocarcinoma (PDAC), because of genetic factors, frequently leads to identification of …
adenocarcinoma (PDAC), because of genetic factors, frequently leads to identification of …
Platelet–leukocyte hybrid membrane‐coated immunomagnetic beads for highly efficient and highly specific isolation of circulating tumor cells
Biomimetic cell‐membrane‐camouflaged nanoparticles with desirable features have been
widely used for various biomedical applications. However, the current research focuses on …
widely used for various biomedical applications. However, the current research focuses on …
[HTML][HTML] Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic …
Background The presence of mutated KRAS (mut KRAS ctDNA) in plasma samples has
been consistently shown to be a negative prognostic indicator in pancreatic cancer (PC) …
been consistently shown to be a negative prognostic indicator in pancreatic cancer (PC) …
Novel SERS labels: Rational design, functional integration and biomedical applications
Driven by the growing demand for healthcare and point-of-care test applications, next-
generation diagnostic tools of diseases require sensing platforms that enable rapid …
generation diagnostic tools of diseases require sensing platforms that enable rapid …
[HTML][HTML] Cancer diagnosis using a liquid biopsy: challenges and expectations
F Castro-Giner, S Gkountela, C Donato, I Alborelli… - Diagnostics, 2018 - mdpi.com
The field of cancer diagnostics has recently been impacted by new and exciting
developments in the area of liquid biopsy. A liquid biopsy is a minimally invasive alternative …
developments in the area of liquid biopsy. A liquid biopsy is a minimally invasive alternative …
A versatile label-free electrochemical biosensor for circulating tumor DNA based on dual enzyme assisted multiple amplification strategy
HF Wang, RN Ma, F Sun, LP Jia, W Zhang… - Biosensors and …, 2018 - Elsevier
A versatile label-free electrochemical biosensor based on dual enzyme assisted multiple
amplification strategy was developed for ultrasensitive detection of circulating tumor DNA …
amplification strategy was developed for ultrasensitive detection of circulating tumor DNA …
Colorectal cancer prevention: immune modulation taking the stage
Prevention or early detection is one of the most promising strategies against colorectal
cancer (CRC), the second leading cause of cancer death in the US. Recent studies indicate …
cancer (CRC), the second leading cause of cancer death in the US. Recent studies indicate …